Microneedle Autoinjector With Transverse Jaws for Viscous Intradermal Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing subcutaneous autoinjectors face challenges in delivering biologics and vaccines due to high viscosity, requiring long injection times and causing discomfort, while intradermal delivery is difficult for self-administration, especially for individuals with reduced dexterity or physical impairments.

Innovation Solution

An automated injection system with a pair of jaws and hollow microneedles that are displaced transversely for intradermal delivery, using a spring-biased plunger to inject medicament through microneedles, allowing single-handed operation and rapid delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Extent of automation

If a single needle is used for subcutaneous injection with spring propulsion, then the injection can be automated, but the injection time is prolonged and patient comfort deteriorates due to high viscosity medicaments

Engineering Contradiction:
Improveautomated injectionVSAvoidinjection time
Core Design Contradiction:
Extent of automationVSLoss of time

Solution Approach 1:

The injection head is divided into a pair of jaws that can move relative to each other, with multiple hollow microneedles on each jaw. This segmentation allows simultaneous injection through multiple needles, significantly reducing injection time while maintaining automation. The jaws can be displaced transversely to insert multiple needles into the skin at once.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from a single vertical needle approach to a multi-dimensional array of microneedles on opposing jaws. The jaws displace transversely (laterally) to insert needles, adding a horizontal dimension to the injection process. This dimensional change enables parallel injection through multiple needles, reducing overall injection time.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Extent of automation

If spring propulsion is used to propel the needle through the skin, then injection can be achieved, but patient comfort worsens due to pain and discomfort

Engineering Contradiction:
Improveinjection capabilityVSAvoidpatient pain and discomfort
Core Design Contradiction:
Extent of automationVSObject-affected harmful factors

Solution Approach 1:

The injection force is distributed across multiple hollow microneedles arranged on two opposing jaws rather than concentrated in a single needle. This segmentation of the injection function reduces the force required per needle and distributes the sensory impact across multiple small points, reducing pain and discomfort while maintaining automated injection capability.

Inventive Principle:
Principle #1Segmentation

3Quantity of substance

If a single needle is used for intradermal delivery, then the procedure offers dose-sparing efficiency, but the operation becomes difficult for self-injection especially for individuals with reduced dexterity

Engineering Contradiction:
Improvedose efficiencyVSAvoidself-injection capability
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The device is designed as an automated injection system where the actuator assembly automatically positions and inserts the microneedles without requiring manual dexterity. The user simply activates the device, and the mechanical system handles the precise intradermal placement, making self-injection accessible to individuals with reduced dexterity while maintaining dose efficiency through controlled delivery.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The actuator assembly uses spring propulsion to rapidly insert the microneedles into the skin, accelerating the injection process. This mechanical acceleration eliminates the need for slow manual insertion, enabling quick and easy self-administration while maintaining precise intradermal delivery for dose efficiency.

Inventive Principle:
Principle #38Strong oxidants (Accelerated oxidation)

4Productivity

If injection pressure is increased to deliver viscous biologics, then delivery speed improves, but device complexity and patient comfort worsen

Engineering Contradiction:
Improvedelivery speedVSAvoidinjection system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The total volume of viscous biologic is distributed across multiple hollow microneedles simultaneously. This segmentation allows the viscous medicament to be delivered through multiple smaller channels in parallel, maintaining delivery speed without requiring excessive pressure that would complicate the device design or compromise patient comfort.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables reliable, self-administered, and repeatable intradermal injection of viscous medicaments with reduced pressure, suitable for various patient types, including those with dexterity issues.

Implementation Method 1

a spring biased plunger in operative association with the piston

Methodology Applied
Scientific EffectSpring mechanism: Spring

Implementation Method 2

a dispenser operable to pressurise the fluid in the reservoir in response to the relative longitudinal displacement between the housing and the actuator assembly in order to dispense the liquid from the one or more hollow microneedles

Methodology Applied
Scientific EffectPressurisation: Pressurisation

Data Source

PatentUS20260077128A1An automated injection system
Publication Date: 2026.03.19 LATCH MEDICAL LTD
  • US20260077128A1 patent drawing
  • US20260077128A1 patent drawing
  • US20260077128A1 patent drawing

AI summary

The present invention provides an automated injection system for transdermal or intradermal delivery of a medicament or the like which provides a robust yet greatly simplified means of operation, the system including an elongate housing forming a handle at one end of which is located an array of 5 microneedles, the injection system further comprising an internal reservoir of the medicament to be injected through the microneedles, and an actuator assembly contained within the housing which is arranged to allow the injection system to be operated by way of a simple one handed grip and press action by the user to both insert the microneedles into the skin and automatically inject the medicament.